-
Product Insights
NewQuarterly Cookies (Sweet Biscuits) pricing trends in Japan
Empower your strategies with our Quarterly Cookies (Sweet Biscuits) pricing trends in Japan report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Product Insights
NewQuarterly Cookies (Sweet Biscuits) pricing trends in the United States
Empower your strategies with our Quarterly Cookies (Sweet Biscuits) pricing trends in the United States report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewQuarterly Cookies (Sweet Biscuits) pricing trends in the United Kingdom
Empower your strategies with our Quarterly Cookies (Sweet Biscuits) pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
Hyndburn Borough City – Accrington Town Square Redevelopment – Lancashire
The Hyndburn Borough City – Accrington Town Square Redevelopment – Lancashire involves the construction and refurbishment of Accrington Market Hall's three sites Market Hall, Market Chambers, and Burtons Chambers. in England, Lancashire, the UK. Equip yourself with the essential tools needed to make informed and profitable decisions with our Hyndburn Borough City – Accrington Town Square Redevelopment – Lancashire report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Branebrutinib in Primary Sjogren’s Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Branebrutinib in Primary Sjogren's Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Branebrutinib in Primary Sjogren's Syndrome Drug Details: Branebrutinib (BMS-986195) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Branebrutinib in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Branebrutinib in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Branebrutinib in Rheumatoid Arthritis Drug Details: Branebrutinib (BMS-986195) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Branebrutinib in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Branebrutinib in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Branebrutinib in Atopic Dermatitis (Atopic Eczema) Drug Details: Branebrutinib (BMS-986195)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-1530 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-1530 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-1530 in Mantle Cell Lymphoma Drug Details: CT-1530 is under development...
-
Thematic Analysis
Connected Consumer in Retail and Apparel – Thematic Intelligence
Connected Consumer in Retail and Apparel Thematic Overview The connected consumer has been created as a direct result of other themes within the retail and apparel sectors. For instance, the Internet of Things (IoT) has transformed the way that retailers and consumers interact. It has allowed retailers to track previously untraceable behaviors, such as tracking coffee replenishment needs through a Bluetooth-connected coffee machine to a retailer’s app. This has raised the bar for the connectivity that consumers expect from retailers...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Branebrutinib in Systemic Lupus Erythematosus
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Branebrutinib in Systemic Lupus Erythematosus Drug Details: Branebrutinib (BMS-986195) is under development for the treatment...